You have accessJournal of UrologyDiscussed Poster, Monday, May 23, 2005, 8:00am - 12:00 pm1 Apr 2005674: The Bicalutamide Early Prostate Cancer Program: Findings of the North American Trial at Median 5.7 Years' Follow-Up David G. McLeod, William A. See, Ira Klimberg, Donald Gleason, Gerald W. Chodak, Tom Morris, and Jon Armstrong David G. McLeodDavid G. McLeod More articles by this author , William A. SeeWilliam A. See More articles by this author , Ira KlimbergIra Klimberg More articles by this author , Donald GleasonDonald Gleason More articles by this author , Gerald W. ChodakGerald W. Chodak More articles by this author , Tom MorrisTom Morris More articles by this author , and Jon ArmstrongJon Armstrong More articles by this author View All Author Informationhttps://doi.org/10.1016/S0022-5347(18)34914-0AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "674: The Bicalutamide Early Prostate Cancer Program: Findings of the North American Trial at Median 5.7 Years' Follow-Up." The Journal of Urology, 173(4S), p. 184 © 2016 by American Urological AssociationFiguresReferencesRelatedDetailsCited ByMcLeod D, See W, Klimberg I, Gleason D, Chodak G, Montie J, Bernstein G, Morris C and Armstrong J (2018) The Bicalutamide 150 Mg Early Prostate Cancer Program: Findings of the North American Trial at 7.7-Year Median FollowupJournal of Urology, VOL. 176, NO. 1, (75-80), Online publication date: 1-Jul-2006. Volume 173Issue 4SApril 2005Page: 184 Advertisement Copyright & Permissions© 2016 by American Urological AssociationMetricsAuthor Information David G. McLeod More articles by this author William A. See More articles by this author Ira Klimberg More articles by this author Donald Gleason More articles by this author Gerald W. Chodak More articles by this author Tom Morris More articles by this author Jon Armstrong More articles by this author Expand All Advertisement Loading ...